Moneycontrol PRO
UPCOMING EVENT:Moneycontrol Pro & Espresso (A Sharekhan Company) in association with Intrazon 2.0 bring to you India’s Largest Retail Intraday Traders Online Conference. Learn 12 Amazing Strategies from 12 Intraday Traders @ Rs. 600/-. Register Now!
you are here: HomeNewscoronavirus

Coronavirus pandemic | Patanjali can't sell Coronil with claims of curing COVID-19: AYUSH Ministry

Patanjali CEO Acharya Balkrishna on Tuesday said the company never claimed Coronil "can cure or control coronavirus infection"

July 01, 2020 / 04:57 PM IST
Image: Twitter/@PypAyurved

Image: Twitter/@PypAyurved

The AYUSH ministry on July 1 said Patanjali Ayurved will not be able to sell its medicine with claims of curing COVID-19. Patanjali had launched Coronil on June 24, and it was prepared under the guidance of yoga guru Baba Ramdev and Patanjali CEO Acharya Balkrishna.

The company had unveiled the drug with claims that Coronil had cured COVID-19 patients, who participated in the trial, within a week. It said the trial was conducted at the privately-run National Institute of Medical Sciences in Jaipur.

Meanwhile, Patanjali said in a statement on July 1 that it had shared its clinical trial documents on Coronil with the AYUSH ministry and 'now there is no difference of opinion between Ayush Ministry and Patanjali.'

"As per the AYUSH ministry, Patanjali is allowed to manufacture and distribute its Divya Coronil Tablet, Divya Swasari Vati and Divya Anu Taila across India, as per the manufacturing licences granted by State Licencing Authority, Ayurvedic and Unani services, Govt of Uttarakhand," the release stated.

While Uttarakhand's Ayurveda department said Patanjali was permitted to manufacture an immunity booster and not a cure for COVID-19, AYUSH Ministry in an email to the Uttarakhand Licencing Authority said the package must not mention 'cure of COVID-19', reported News18.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

“It may be ensured that on the package and label displayed on the medicines (Divya Coronil Tablet and Divya Shwashari Vati), no claim for the cure of Covid-19 should be mentioned,” said the drug policy section of the AYUSH ministry in an email to the Uttarakhand Licencing Authority.

Track this blog for LIVE updates on the COVID-19 outbreak

The email further said the advertisement and the publicity of the drugs should be ensured in accordance with the relevant provisions of the Drugs and Magic Remedies.

Patanjali, in its reply, asserted that it had neither claimed to treat the COVID-19 nor had it printed any symbolic photograph of the virus on the label of the medicine.  “Upon inspection, our team found that Coronil label carries a symbolic photo of the virus. We have asked Patanjali to remove any graphic or such claim,” said YS Rawat, state drug licence official.

Balkrishna, too, on Tuesday said the company never claimed its medicine, Coronil, "can cure or control corona". "We never told the medicine (Coronil) can cure or control corona. We said we had made medicines and used them in a clinical trial which cured corona patients. There is no confusion in it," Balkrishna told news agency ANI.

Click here for Moneycontrol's full coverage of the coronavirus pandemic
Moneycontrol News
first published: Jul 1, 2020 04:16 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark